Dedicated two-stent technique in complex bifurcation percutaneous coronary intervention with use of everolimus-eluting stents: The EES-bifurcation study

Objectives

To compare the outcomes of initial one-stent (1S) versus dedicated two-stent (2S) strategies in complex bifurcation percutaneous coronary intervention (PCI) using everolimus-eluting stents (EES).

Background

PCI of true bifurcation lesions is technically challenging and historically associated with reduced procedural success and increased restenosis. Prior studies comparing initial one-stent (1S) versus dedicated two-stent (2S) strategies using first-generation drug-eluting stents have shown no reduction in ischemic events and more complications with a 2S strategy.

Methods

We performed a retrospective study of 319 consecutive patients undergoing PCI at a single referral center with EES for true bifurcation lesions, defined by involvement of both the main vessel (MV) and side branch (SB). Baseline, procedural characteristics, quantitative coronary angiography and clinical outcomes in-hospital and at one year were compared for patients undergoing 1S (n = 175) and 2S (n = 144) strategies.

Results

Baseline characteristics were well-matched. 2S strategy was associated with greater SB acute gain (0.65 ± 0.41 mm vs. 1.11 ± 0.47 mm, p < 0.0001). In-hospital serious adverse events were similar (9% with 2S vs. 8% with 1S, p = 0.58). At one year, patients treated by 2S strategy had non-significantly lower rates of target vessel revascularization (5.8% vs. 7.4%, p = 0.31), myocardial infarction (7.8% vs. 12.2%, p = 0.31) and major adverse cardiovascular events (16.6% vs. 21.8%, p = 0.21).

Conclusion

In this study of patients undergoing PCI for true coronary bifurcation lesions using EES, 2S strategy was associated with superior SB angiographic outcomes without excess complications or ischemic events at one year.     

Three-year Follow-up of Patients With Bifurcation Lesions Treated With Sirolimus- or Everolimus-eluting Stents: SEAside and CORpal Cooperative Study

Introduction and objectives

To compare the 3-year incidence of major events in patients with bifurcation lesions treated with provisional sirolimus-eluting stents vs everolimus-eluting stents.

Methods

A pooled analysis of 2 prospective randomized trials with similar methodology (SEAside and CORpal) was performed. In these trials, 443 patients with bifurcation lesions were randomly assigned to treatment with either sirolimus-eluting stents or everolimus-eluting stents. The clinical follow-up was extended up to 3 years to assess major adverse cardiovascular events (death or acute myocardial infarction or target vessel revascularization).

Results

At 3 years, survival free of major adverse cardiovascular events was 93.2% vs 91.3% in the everolimus-eluting stent group vs the sirolimus-eluting stent group (P = .16). Exploratory land-mark analysis for late events (occurring after 12 months) showed significantly fewer major adverse cardiovascular events in the everolimus-eluting stent group: 1.4% vs 5.4% in the sirolimus-eluting stent group (P = .02).

Conclusions

Provisional stenting with either sirolimus-eluting stents or everolimus-eluting stents in bifurcation lesions is associated with low rates of major adverse events at 3-years’ follow-up. The results of a subanalysis of events beyond 1 year, showing a lower event rate with everolimus-eluting stents than with sirolimus-eluting stents, suggest that studies exploring the long-term clinical benefit of the latest generation of drug-eluting stents are warranted.     

胎盘生长因子在慢性哮喘大鼠肺组织中的表达

 目的 探讨胎盘生长因子(placenta growth factor,PlGF)在慢性哮喘大鼠肺组织中的表达。方法 45只雄性SD大鼠随机分为3组(每组15只):(1)正常大鼠组(A组):未行特殊干预处理;(2)卵清蛋白(ovalbumin,OVA)致敏及生理盐水吸入大鼠组(B组):应用OVA致敏生理盐水激发;(3)慢性哮喘大鼠组(C组):应用OVA致敏和反复激发制备大鼠慢性哮喘模型。各组大鼠于末次激发后24 h处死。ELISA法测定肺泡灌洗液(BALF)中PlGF水平;大鼠肺组织标本行HE染色、PAS染色及Masson三色染色,并行病理图像形态学测定和分析;免疫组化检测大鼠气道上皮细胞PlGF的表达。结果 慢性哮喘大鼠组(C组)气道上皮细胞PlGF的表达(PI为2.28±0.18)与正常大鼠组(A组)及OVA致敏生理盐水吸入大鼠组(B组),(PI分别为0.89±0.08、0.94±0.12)相比明显增多(A组与C组比较P<0.01,B组与C组比较P<0.01)。慢性哮喘大鼠组(C组)BALF中PlGF水平(18.87±4.53)ng/ml与正常大鼠组(A组)及OVA致敏生理盐水吸入大鼠组(B组),分别为(12.35±1.94)ng/ml、(13.14±2.52)ng/ml相比明显增高(P<0.05)。结论 胎盘生长因子(PlGF)在慢性哮喘大鼠肺组织中表达增多。     

青少年特发性脊柱侧凸腰主弯患者腰椎-骨盆的生物力学分析

文题释义： 青少年特发性脊柱侧凸：为脊柱三维平面上的畸形,会导致青少年脊柱结构发生明显的改变,结构的改变会导致椎骨及椎间盘应力发生相应的改变,且腰椎、骨盆在人体中的力学作用极为重要,青少年时期为人体脊柱生长发育的高峰期,脊柱结构及应力的改变在该时期的进展尤为明显。 背景：青少年特发性脊柱侧凸导致脊柱结构和应力发生改变,腰椎在脊柱中承受的载荷最大,骨盆也起着传导重力的作用,故青少年特发性脊柱侧凸腰主弯患者腰椎骨盆的生物力学分析尤为重要。 目的：建立青少年特发性脊柱侧凸腰主弯腰椎-骨盆三维数字化模型并进行有限元分析。 方法：根据1例13岁女性特发性脊柱侧凸腰主弯患者的腰椎-骨盆CT薄层数据,应用Mimics 15.0软件重建三维数字化模型,以Pro/E 5.0软件建立初步几何模型并导入Hypermesh 13.0进行网格划分,最终通过Abaqus 6.14软件对该模型进行有限元分析。分析有限元模型在6种载荷条件下的位移、应力变化及该模型各椎体及椎间盘的应力变化。患者家属对试验方案知情同意,且得到医院伦理委员会批准。 结果与结论：①建立了青少年特发性脊柱侧凸腰主弯患者的腰椎-骨盆的三维有限元模型;②模型在6种载荷条件下,L₁椎体上部在左、右侧屈时位移变化最大,骶骨下端在前屈时位移最大;③椎间盘右缘在右侧屈运动条件下所受应力最大;前屈位时,腰椎间盘所受应力为前缘最大,左缘所受应力最小;后伸位时后缘所受应力最大,而右缘所受应力最小;侧屈位及旋转位时,右缘所受应力最大,前缘所受应力最小;④L₅在6种运动中应力均最大,其中应力集中于上下关节突及椎弓根,尤其以右侧最为集中;⑤提示青少年特发性脊柱侧凸不同载荷会引起椎体或椎间盘不同位置受力及位移有相应变化,研究结果对脊柱侧凸的治疗和预防具有重要意义。 ORCID: 0000-0001-5810-6674(张聪) 中国组织工程研究杂志出版内容重点：组织构建;骨细胞;软骨细胞;细胞培养;成纤维细胞;血管内皮细胞;骨质疏松;组织工程     

ALK-negative anaplastic large cell lymphoma primarily involving the bronchus: a case report and literature review

Anaplastic large cell lymphoma (ALCL) is a mature T cell lymphoma with characteristic morphologic, immunophenotypic and cytogenetic features. Current WHO classification includes anaplastic lymphoma kinase (ALK)-positive and ALK-negative variants. ALCL rarely presents with obstructive symptoms of the main airway. In addition to reporting a HIV-associated bronchial ALK-negative ALCL in a 44 year-old female, our literature review identified eight cases of bronchial ALCL with several interesting clinicopathological features, including: 1) a female predominance (67%); 2) two thirds of patients younger than 18 years old; 3) uniformly presented with respiratory symptoms and progressed to respiratory failure; 4) the tumor involving the main airways; 5) often with localized disease at the initial presentation. This unusual presentation of ALCL may pose as a diagnostic pitfall and delay the treatment.     

英国伦理委员会的现状与分析

伦理委员会的主要职责是保护药物临床试验受试者的权益、安全和健康.现对英国伦理委员会的法律、法规、申请及审评程序等进行归纳分析,旨在对规范我国伦理委员会的运作具有参考借鉴作用.     

随机单位组析因设计资料例析

通过实例对随机单位组的析因设计方法特点、如何应用SPSS软件处理此类数据以及如何在论文中对统计分析结果正确表达进行了介绍。